Search or choose
Find the right test or package.
PulmoCORE 12 gene panel - 2
pulmoCORE 12 gene panel-2 is a next generation sequencing based assay that identifies genetic changes (mutations) in 12 different genes associated with Non-Small Cell Lung Cancer (NSCLC). This panel includes testing of all the relevant genes that are most freq...
DiagnosticsLab test
Know more about this test
pulmoCORE 12 gene panel-2 is a next generation sequencing based assay that identifies genetic changes (mutations) in 12 different genes associated with Non-Small Cell Lung Cancer (NSCLC). This panel includes testing of all the relevant genes that are...
Understanding PulmoCORE 12 gene panel - 2
pulmoCORE 12 gene panel-2 is a next generation sequencing based assay that identifies genetic changes (mutations) in 12 different genes associated with Non-Small Cell Lung Cancer (NSCLC). This panel includes testing of all the relevant genes that are most frequently altered NSCLC including ALK, BRAF, EGFR, ERGG2, KRAS, MAP2K1, MET, NRAS, PIK3CA, RET, ROS1 and TP53. It uses a specialized Ventana PD-L1 SP263 predictive assays which identify patients who are most likely to respond to specific therapies related to NSC...
What does PulmoCORE 12 gene panel - 2 measure?
pulmoCORE 12 gene panel-2 is a next generation sequencing based assay that identifies genetic changes (mutations) in 12 different genes associated with Non-Small Cell Lung Cancer (NSCLC). This panel includes testing of all the relevant genes that are most frequently altered NSCLC including ALK, BRAF, EGFR, ERGG2, KRAS, MAP2K1, MET, NRAS, PIK3CA, RET, ROS1 and TP53. It uses a specialized Ventana PD-L1 SP263 predictive assays which identify patients who are most likely to respond to specific therapies related to NSC...
Related parameters
How does home sample collection work?
Select slot
Pick a convenient time.
Phlebotomist visit
A trained expert arrives home.
Safe testing
Samples move through the lab process.
Digital reports
Reports are delivered online.